BR0308987A - Agentes antidiabéticos - Google Patents

Agentes antidiabéticos

Info

Publication number
BR0308987A
BR0308987A BR0308987-8A BR0308987A BR0308987A BR 0308987 A BR0308987 A BR 0308987A BR 0308987 A BR0308987 A BR 0308987A BR 0308987 A BR0308987 A BR 0308987A
Authority
BR
Brazil
Prior art keywords
formula
antidiabetic agents
compounds
preparing compounds
useful
Prior art date
Application number
BR0308987-8A
Other languages
English (en)
Inventor
Christopher Franklin Bigge
Robert Philipp Schaum
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0308987A publication Critical patent/BR0308987A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"AGENTES ANTIDIABéTICOS". A presente invenção refere-se a compostos de fórmula I: em que X, Y, B, E, J, K, L, Z, e R~ 9~-R~ 12~ têm qualquer dos significados aqui descritos, os seus sais farmaceuticamente aceitáveis, baixam os níveis de glicose e são úteis para o tratamento de doenças em mamíferos tais como a Diabetes Mellitus Não-Dependente de Insulina. Também descritas estão composições farmacêuticas, processos para preparação de compostos de fórmula (I) e intermediários úteis para preparação de compostos de fórmula I.
BR0308987-8A 2002-04-03 2003-03-25 Agentes antidiabéticos BR0308987A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36978702P 2002-04-03 2002-04-03
PCT/IB2003/001131 WO2003082276A1 (en) 2002-04-03 2003-03-25 Antidiabetic agents

Publications (1)

Publication Number Publication Date
BR0308987A true BR0308987A (pt) 2005-01-04

Family

ID=28675585

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308987-8A BR0308987A (pt) 2002-04-03 2003-03-25 Agentes antidiabéticos

Country Status (8)

Country Link
US (1) US6696474B2 (pt)
EP (1) EP1490060A1 (pt)
JP (1) JP2005527554A (pt)
AU (1) AU2003215803A1 (pt)
BR (1) BR0308987A (pt)
CA (1) CA2481258A1 (pt)
MX (1) MXPA04009499A (pt)
WO (1) WO2003082276A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1838968A (zh) 2003-08-08 2006-09-27 艾伯吉尼斯公司 针对甲状旁腺激素(pth)之抗体和其用途
US7318925B2 (en) * 2003-08-08 2008-01-15 Amgen Fremont, Inc. Methods of use for antibodies against parathyroid hormone
US8288438B2 (en) * 2005-03-21 2012-10-16 Metabolex, Inc. Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer
BRPI0711416A2 (pt) * 2006-05-11 2011-11-01 Sanofi Aventis ácidos carboxìlicos substituìdos com 4,5-difenil pirimidinila, processo para a produção e uso dos mesmos como medicamentos

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK161499A3 (en) * 1998-03-30 2000-06-12 Japan Tobacco Inc Process for producing isooxazolidinedione compound
KR100613175B1 (ko) 1998-08-27 2006-08-17 오노 야꾸힝 고교 가부시키가이샤 카르복실산 유도체 및 그 유도체를 유효 성분으로서함유하는 약제

Also Published As

Publication number Publication date
JP2005527554A (ja) 2005-09-15
CA2481258A1 (en) 2003-10-09
US20030220381A1 (en) 2003-11-27
AU2003215803A1 (en) 2003-10-13
EP1490060A1 (en) 2004-12-29
MXPA04009499A (es) 2005-01-25
US6696474B2 (en) 2004-02-24
WO2003082276A1 (en) 2003-10-09

Similar Documents

Publication Publication Date Title
ATE425166T1 (de) Amidderivate von 3-phenyldihydropyrimidoä4,5- düpyrimidinonen, deren herstellung und verwendung als pharmazeutische mittel
BR0317435A (pt) Derivados de pirimidina para o tratamento do crescimento celular anormal
ATE469161T1 (de) Pyrazolderivat, dieses enthaltende medizinische zusammensetzung, medizinische verwendung davon, und zwischenprodukt für dessen herstellung
WO2003024965A3 (en) Heterocyclic compounds that are inhibitors of the enzyme dpp-iv
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
CA2474578A1 (en) Novel pyridin- and pyrimidin-derivatives
BRPI0112986B8 (pt) compostos azabicíclicos, processo para a sua preparação, bem como composições farmacêuticas compreendendo os ditos compostos
BR0008202A (pt) Derivados de quinolin-2-ona substituìdos com heteroarilas úteis como agentes contra o câncer
SE0001899D0 (sv) New compounds
DE50309979D1 (de) Neue purinderivate, deren herstelllung und deren verwendung als arzneimittel
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
EP1400529A4 (en) GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND MEDICINAL AND INTERMEDIARY USE THEREOF
MX2007010532A (es) Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii.
ATE427926T1 (de) Cycloalkylaminderivate
BR0308212A (pt) Composto, composição farmacêutica, e, uso de um composto
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
BRPI0510394A (pt) inibidores de 11-beta-hidroxiesteróide desidrogenase tipo 1
HK1050369A1 (en) Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof.
BR0116402A (pt) Derivados de tetrahidropiridina, sua preparação e sua utilização como inibidores de proliferação celular
GB2454615A (en) Antidiabetic azabicyclo (3.1.0) hexan compounds
BRPI0411891A (pt) pirazol[3,4-b]piridin-6-onas como inibidores de gsk-3
NO20072389L (no) Substituerte benzokinolizinderivater
BR0212069A (pt) Agentes antidiabéticos orais

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A, 5A E 6A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.